International Grants

Research Projects funded by the European Commission

Reference GA 101156566
Title Synapsing Mental Disorders and Neurodegenerative diseases: Towards more effective diagnosis and management of psychiatric symptoms (SYNAPSING)
Principal Investigator Olivia Belbin
Execution dates January 2025 – December 2029
Budget 1.014.147,08€
Call HORIZON-HLTH-2024-DISEASE-03-14-two-stage 

Reference GA 101126533
Title Towards the next generatiOn of excellent yoUng doctoral researchers on mental health by developing an intersectoral & transdisciplinary approaCH (TOUCH)
Principal Investigator Maria Portella
Execution dates February 2024 – January 2029
Budget 84.600€
Call  HORIZON-MSCA-2022-COFUND-01

Reference GA 101057554
Title An early warning and response system for the detection and prevention of vector-borne disease importation and spread in the Mediterranean (IDAlert)
Principal Investigator Tomas Montalbo
Execution dates June 2022 – May 2027
Budget 93.917€
Call  HORIZON-HLTH-2021-ENVHLTH-02

Reference GA 894990
Title Living Evidence to inform health decisions: Development of capacity for the production and use of reliable, friendly and updated health evidence synthesis (LIVING EVIDENCE)
Principal Investigator María Ximena Rojas-Reyes
Execution dates September 2020 – September 2022
Budget 172.932,48€
Call  H2020-MSCA-IF-2019

Reference GA 733297
Title European Endeavour for Chimeric Antigen Receptor Therapies (EURE-CART)
Principal Investigator Jordi Sierra
Execution dates January 2017 – June 2021
Budget 147.295€
Call H2020-SC1-PM09-EURE-CART

Reference GA 101016072
Title Medical technologies, digital tools and artificial intelligence analytics to improve surveillance and care at high technology read lines (COVIRNA)
Principal Investigator Lina Badimon
Execution dates November 2020 – April 2023
Budget 273.942,50€
Call  SC1-PHE-CORONAVIRUS-2020-2CNET

Reference GA 945393
Title Accelerating Development and improving access to car and TCR engineered TC THERAPY (T2EVOLVE)
Principal Investigator Javier Briones
Execution dates January 2021 – December 2025
Budget 271.310€
Call H2020-JTI-IMI2-2019-18-two-stage

Reference GA 965422
Title Multidisciplinary Expert System for the Assessment & Management of Complex Brain Disorders (Mes-CoBraD)
Principal Investigator Juan Fortea
Execution dates April 2021 – September 2024
Budget 482.771,25€
Call H2020-SC1-BHC-2018-2020

Reference GA 821283
Title Translational Safety Biomarker Pipeline: Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease (TransBioLine)
Principal Investigator Lina Badimon
Execution dates February 2019 – January 2025
Budget 182.600€
Call H2020-JTI-IMI2-2017-13-two-stage

Reference GA 821508-11
Title Cardiomyopathy in type 2 diabetes mellitus (CARDIATEAM)
Principal Investigator Lina Badimon
Execution dates March 2019 – February 2024
Budget 50.000€
Call H2020-JTI-IMI2-2017-13-two-stage

Reference GA 853989
Title European Regimen Accelerator for Tuberculosis project (ERA4TB)
Principal Investigator Rosa Antonijoan
Execution dates January 2020 – December 2025
Budget 277.500 €
Call  Innovative Medicines Initiative 2 Joint Undertaking (JU)

Reference SOE4/P1/E1063
Title Network of excellence for the development of advanced therapies for the treatment of myocardial infractions based on regenerative medicine and 3D printing (CARDIOPATCH)
Principal Investigator Lina Badimon
Execution dates September 2020 – 30 April 2023
Budget  123.750€
Call Interreg Sudoe (EU)

Reference GA 754936
Title Comparing effectiveness of self-management interventions in 4 high priority chronic diseases in Europe (COMPAR-EU)
Principal Investigator Pablo Ignacio Alonso
Execution dates January 2018 – December 2022
Budget  777.786,25€
Call  H2020-SC1-2016-2017 (two-stage)

Research Projects funded by EU Joint Actions 

Reference ADTKD-Net
Title Autosomal Dominant Tubulointerstitial Kidney Disease-Net a European Registry Based Clinical Research Platform (ADTKD-Net)
Principal Investigator Roser Torra
Execution dates January 2024 – December 2026
Budget 166.875€
Call EJP RD JTC 2023

Reference OptiMyG
Title Characterization and optimization of myasthenia gravis care.
Principal Investigator Eduard Gallardo
Execution dates January 2024 – December 2026
Budget 174.918€
Call  EJP RD JTC 2023

Reference EJPRD23-010
Title CADASIL-Historia Natural (CADANHIS)
Principal Investigator Israel Fernández
Execution dates January 2024 – December 2026
Budget 179.375€
Call EJP RD JTC 2023

Reference LANTERN
Title Cancer Multi-omics Avatars for Integrated Precision Medicine.
Principal Investigator Nuria Farré
Execution dates January 2023 – December 2025
Budget 198.202€
Call  ERA PerMed JTC2022

Reference BIPCOM
Title Medical Comorbities In Bipolar Disorder: Clinical Validation of Risk Factors and Biomarkers to Improve Prevention and Treatment. 
Principal Investigator Rosa Corcoy
Execution dates January 2023 – December 2025
Budget 199.977€
Call  ERA PerMed JTC2022

Reference NANOFIB
Title Targeted NANOmedicine to reverse FIBrosis in ischemic cardiomyopathies’.
Principal Investigator Gemma Vilahur
Execution dates January 2024 – December 2026
Budget 174.999€
Call  M-ERA.NET Joint Call 2022

Reference  bPRIDE
Title blood Proteins for early Discrimination of dEmentias
Principal Investigator Albert Lleó
Execution dates January 2020 – December 2022
Budget 99.825€
Call  JPND “Multinational research projects on Personalised Medicine for Neurodegenerative Diseases”

Reference  iBioStroke
Title Identificación y validación clínica de biomarcadores para la evolución clínica post-ictus 
Principal Investigator Israel Fernández
Execution dates January 2020 – December 2022
Budget 93.170€
Call  ERA-NET NEURON

Reference HOLY-2020
Title Improved treatment stratification for Hodgkin lymphoma patients through the use of deep learning, molecular imaging and relevant clinical data.
Principal Investigator Ignasi Carrió
Execution dates January 2020 – December 2022
Budget 99.999,24€
Call  ERACoSysMed 3rd Joint Transnational Call for European Research Projects on Systems Medicine

Reference PREVENT-VCI
Title Boosting cholesterol trafficking and reducing cellularoxidation to reverse atherosclerosis and prevent vascular cognitive impairment. 
Principal Investigator Lina Badimon
IRSP funding January 2021 – December 2023
Budget 174.978,1€
Call ERA-CVD JTC 2020

Reference SynaDeg
Title Prediagnostic early synaptic disturbances in neurodegenerative diseases.
Principal Investigator Olivia Belbin
Execution dates January 2022 – December 2024
Budget 154.880€
Call  JPND

Reference TREAT-SNGAP
Title Synaptic Dysfunction in Intellectual Disability Caused by SYNGAP1. Translational Research to Develop Human Models and Advance Pharmacological Treatments.
Principal Investigator Alejandro Bayes
Execution dates May 2018 – December 2021
Budget  149.435€
Call  ERA-NET NEUTRON 2017

Research projects funded by ERASMUS + PROGRAMMES

Reference 2021-1-BE02-KA220-HED-000032124
Title Erasmus+ cooperation for multidisciplinary training in radioligand therapies for healthcare professionals
Principal Investigator Albert Flotats / Former PI: Ignasi Carrió
Execution dates February 2022 – July 2024
Budget  33.520€
Call Erasmus+ RLT Academy

Reference 2018-1-NL01-KA203-039070
Title European partnership on Competencies for high Value Cost Conscious Care (COCOCARE)
Principal Investigator Pablo Ignacio Alonso
Execution dates September 2018 – December 2021
Budget  47.460€
Call 2019/07/CoCoCare

Research projects funded by the National Institutes of Health 

Reference5R01AG073267-04
TitleLongitudinal multicenter head-to-head harmonization of tau PET tracers (HEAD)
Principal Investigator Alberto Lleo
Execution dates June 2024 – May 2025
Estimated budget544.320,00$
Call R01/ PA-20-185

Reference 1R01AG080470-01
Title Bilingual Factors Associated with Cognitive Reserve and Linguistic Resilience in Hispanics with Primary Progressive Aphasia
Principal Investigator Miguel Ángel Santos
Execution dates December 2022 – November 2027
Estimated budget 1.071.088,62$
Call R01/ RFA-AG-23-001

Reference 5U01NS102289-03
Title SATURN – StATins Use in intRacerebral hemorrhage patieNts (SATURN)
Principal Investigator Joan Martí Fàbregas
Execution dates December 2023 – December 2026
Estimated budget 999.990$
Call U01/ PAR-17-274

Reference 1RF1AG080769-01
Title Sleep and Temperature Disturbance as risk factors for Alzheimer’s Disease in Down Syndrome: a Longitudinal Study
Principal Investigator Juan Fortea
Execution dates January 2023 – January 2026
Estimated budget  796.416$
Call R01 / PAR-22-093

Reference 5R01NS121218-02
Title Elucidating the Key Mediators and Mechanisms of Cerebral Edema and Hemorrhagic Transformation after Hemispheric Stroke using Quantitative Imaging and Genetics
Principal Investigator Israel Fernández
Execution dates June 2023 – May 2027
Estimated budget 340.986$
Call R01 / PA-20-185

Reference 1U01NS110772-01
Title FVIIa for Acute hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial
Principal Investigator Joan Martí Fàbregas
Execution dates November 2022 – December 2024
Estimated budget 65.482,60$
Call U01/ PAR-18-561

Reference 1R61AG066543-01
Title Clinical trials to prevent Alzheimer’s Disease in Down Syndrome
Principal Investigator Juan Fortea
Execution dates September 2019 – August 2024
Estimated budget 450.000$
Call R61/R33/RFA-OD-19-018

Reference 1R01AG056850-01A1
Title The Role of Inflammation and NGF Dysfunction in the Evolution of Alzheimer Disease Pathology in Down syndrome
Principal Investigator Juan Fortea
Execution dates: April 2018 – August 2023
Estimated budget: 505.205$
Call R21 /PA-16-161

Reference 3RF1AG056850-01S1
Title The Role of Inflammation and NGF Dysfunction in the Evolution of Alzheimer Disease Pathology in Down syndrome
Principal Investigator Juan Fortea
Execution dates: April 2018 – August 2023
Estimated budget: 1.199.788$
Call R21 /PA-16-161

Reference 3RF1AG056850-01A1S1
Title The Role of Inflammation and NGF Dysfunction in the Evolution of Alzheimer Disease Pathology in Down syndrome
Principal Investigator Juan Fortea
Execution dates: April 2018 – August 2023
Estimated budget 322.294$
Call R01 /PA-18-484

Reference 5R01HL154385-04
Title Structural and Nucleotide Variation as Genomic Risks for Venous Thrombosis: TOPMED and INVENT Collaboration 
Principal Investigator Maria Sabater
Execution dates January 2022 – July 2024
Estimated budget 25.000$
Call R01 /PA-19-056

Reference 1R01NS114045-01
Title CNV And Stroke (CaNVAS)
Principal Investigator Israel Fernández
Execution dates January 2020 – November 2024
Estimated budget 115.510$
Call R01/ PA-19-056

Reference 5R01HL134894-04
Title Population genomic variation, functional biology and the risk of venous thrombosis.
Principal Investigator Maria Sabater-Lleal
Execution dates August 2018 – July 2023
Estimated budget:  69.093$ 
Call R01/PA-16-160

Research projects funded by the Jérôme Lejeune Fondation

Reference 2326_2024a
Title Reduced Learning Over Repeated Exposures and its Association with Preclinical Alzheimer’s Disease in Down Syndrome: A Novel Digitalized Outcome Measure for Preventive Clinical Trials .
Principal Investigator Laura del Hoyo
Execution dates October 2024 – October 2026
Budget 49.985€
Call Research Project Grants 2023

Reference JLF 1801-GRT-2018b
Title Assessing the role of the peripheral immune system in the Down Syndrome population
at different stages of Alzheimer’s Disease using single-cell RNA sequencing
Principal Investigator Oriol dols
Execution dates January 2024 – January 2026
Budget 130.000€
Call Post-Doctoral Fellowship 2023

Reference JLF 1801-GRT-2018b
Title The impact of Alzheimer’s disease on sleep in adults with Down Syndrome
Principal Investigator Sandra Giménez
Execution dates February 2020 – July 2024
Budget 86.699,13€
Call Advanced Grants 2018

Reference JLF 2018-2
Title Discovery of novel biomarkers signalling NGF metabollic dysfunction and early AD-dementia in Down syndrome
Principal Investigator Maria Florencia Iulita
Execution dates January 2020 – September 2022
Budget 154.000€
Call Post-Doctoral Fellowship 2017

Reference JLF 1941_2020a
Title ProNGF and NfL in neuron-derived extracellular vesicles: the gateway to blood biomarker discovery for Alzheimer´s disease prevention in Down syndrome
Principal Investigator Maria Iulita
Execution dates July 2020 – July 2022
Budget 39.999,60€
Call Research Project Grants 2020

Reference JLF 1913
Title Inflammatory biomarkers along the Alzheimer’s disease continuum in down syndrome
Principal InvestigatorMaria Carmona
Execution dates June 2020 – February 2023
Budget 86.694,20€
Call Research Project Grants 2020

Research projects funded by the Alzheimer’s Association

Reference IGPCC-B-1264114
Title Genetically Determined AD: Cross-fertilization between DSAD and ADAD
Principal Investigator Juan Fortea
Execution dates January 2024 – December 2024
Budget 25,000.00$
Call ISTAART Grant Program for Conferences and Convenings (IGPCC) 2023

Reference SG-23-1014431 iLEADS
Title iLEADS Start Up Funding: FIR-HSP
Principal Investigator Alberto Lleó
Execution dates  September 2022 – August 2023
Budget 59,925.00$
Call ALZ Strategic Initiatives 2023

Reference AARG-22-923680
Title Multimodal imaging of small vessel disease in genetic AD
Principal Investigator Alex Bejanin
Execution dates August 2022 – July 2025
Budget 149,994.46$
Call Alzheimer’s Association Research Grant (AARG) 2022

Reference AARF-22-924456
Title Assessing peripheral inflammation in DS at different stages of AD
Principal Investigator Oriol Dols
Execution dates August 2022 – July 2025
Budget 174,990.00$
Call Alzheimer’s Association Research Fellowship (AARF)  2022

Reference AACSF-22-972945
Title Molecular bases of bilingualism’s protective effect vs cognitive decline
Principal Investigator Miguel Ángel Santos
Execution dates January 2023 – December 2025
Budget 174,972.94$
Call Alzheimer’s Association Clinician Scientist Fellowship (AACSF) 2022

Reference AARG-22-973966
Title Multimodal assessment of brain inflammatory biomarkers in DS-associated AD
Principal Investigator Maria Carmona
Execution dates January 2023 – December 2025
Budget 174,972.94$
Call Alzheimer’s Association Research Grant (AARG) 2022

Reference AARG-22-974373
Title Role of synaptic miRNA and astrocyte miRNA delivery in Alzheimer’s disease
Principal Investigator Olivia Belbin
Execution dates December 2022 – November 2025
Budget 149,949.56$
Call Alzheimer’s Association Research Grant (AARG) 2022

Reference AACSF-21-850193
Title Unveiling the impact of biological sex along sporadic and genetic FTLD
Principal Investigator Ignacio Illán
Execution dates November 2021 – October 2024
Budget 174,595.82$
Call Alzheimer’s Association Clinician Scientist Fellowship (AACSF) 2021

Reference AARFD-21-852492
Title Evaluation of cortical microinfarcts in individuals with Down syndrome
Principal Investigator Matheus Aranha
Execution dates February 2022 – January 2025
Budget 175,000.00$
Call Alzheimer’s Association Research Fellowship to Promote Diversity (AARF-D) 2021

Research projects funded by the Global Brain Health Institute (GBHI), the Alzheimer’s Association, and the Alzheimer’s Society UK

Reference GBHI ALZ UK-23-971107
Title Evaluation of the circadian rest-activity rhythm in adults with DS
Principal InvestigatorSandra Giménez
Execution dates February 2023 – January 2026
Budget 24.987$
Call Pilot GBHI ALZ ASS

Research projects funded by the Association for Frontotemporal Degeneration

Reference AFTD 2019-003
Title Identification of an RNA-based biomarker in FTD
Principal Investigator Oriol Dols
Execution dates January 2020 – December 2022
Budget 110.106$
Call 2019-2021 Clinical Research Postdoctoral Fellowship

Research projects funded by GBS CIDP Foundation International

Reference GBS/CDIP 2022
Title Biomarkers in the diagnosis and follow-up of CIDP
Principal Investigator Elba Pascual
Execution dates January 2022 – January 2025
Budget 397.650$
Call Benson Clinical Research Fellowship 2022

Reference GBS/CIDP 2020
Title Precision medicine in chronic inflammatory neuropathy assessment
Principal Investigator Luis Antonio Querol
Execution dates June 2020 – January 2024
Budget 59.450$
Call Research Grants 2020

Research projects funded by the Fanconi Anemia Research Fundation (FARF)

Reference  AFAN TRIAL
Title  AFAN Trial. Phase IB/II Study to Investigate the Safety and Efficacy of Afatinib When Administered as Therapy in Fanconi Anemia Patients with Unresectable and/or Metastatic Locoregionally Advanced Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Hypopharynx, or Larynx
Principal Investigator  Jordi Surrallés
Execution dates April  2023 –  April 2027
Budget 324,733$
Call Fanconi Anemia Research Fund Research Grant Award

Reference FARF 2022
Title Afatinib therapy for Head and Neck Squamous Cell Carcinomas in Fanconi anemia
Principal Investigator Jordi Surrallés
Execution dates March 2021-December 2022
Budget 60,000$
Call FARF Research Grants Award

Research projects funded by the Gates Foundation

Reference OPP1126780 GATES
Title Study of genomic disease burden to complement Cause of Death investigation in Sub-Saharan African: a pilot study from Child Health and Mortality Prevention Surveillance (CHAMPS) Network 
Principal Investigator Susana Boronat
Execution dates February 2023 – January 2025
Budget 277.950$
Call Gates Foundation